# A Multiple Synergic Treatment for Non-Healing Ulcer Management in a Patient with Klippel–Trenaunay Syndrome

**Authors:** Cristina Vocca, Gianmarco Marcianò, Vincenzo Rania, Luca Catarisano, Caterina Palleria, Salvatore Ciranni, Giuseppina Torcia, Raffaele Serra, Francesco Monea, Giuseppe Spaziano, Giovambattista De Sarro, Rita Citraro, Luca Gallelli

PMC · DOI: 10.3390/reports6030033 · Reports · 2023-07-20

## TL;DR

This paper presents a successful multi-treatment approach for a severe skin ulcer in a patient with Klippel–Trenaunay syndrome, a rare genetic disorder.

## Contribution

The first reported case of a synergistic treatment combining oxygen-ozone therapy, pulsed magnetic fields, and a topical compound for KTS-related ulcers.

## Key findings

- A combination of oxygen-ozone therapy and pulsed magnetic fields improved the patient's non-healing ulcer.
- A topical formulation containing cocum caprylate, oleic acid, quercetin, and 18-β glycyrrhetinic acid contributed to ulcer healing.
- This case supports a multistep treatment strategy for managing severe symptoms in Klippel–Trenaunay syndrome.

## Abstract

Klippel–Trenanauy syndrome (KTS) is a rare genetic disease determined by overexpression of the phosphatidylinositol-4-5-bisphosphate 3 kinase catalytic subunit (PIK3CA) gene. The clinical presentation is characterized by venous and capillary malformations and lymphatic malformation. To date, no definitive treatment has been suggested in order to improve the clinical symptoms related to the developments of a skin wound. In this case, we describe a young man with KTS that developed a severe skin wound in the lower right limb unresponsive to the common treatment but responsive to a treatment with oxygen-ozone therapy, pulsed magnetic fields (diamagnetic treatment), and topical fixed association of cocum caprylate, oleic acid, quercetin, and 18-β glycyrrhetinic acid. This is the first case that supports a multistep approach to treat a rare and severe disease, and we hope that other studies can support our data.

## Linked entities

- **Genes:** PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290]
- **Chemicals:** oxygen-ozone (PubChem CID 131711318), oleic acid (PubChem CID 445639), quercetin (PubChem CID 5280343), 18-β glycyrrhetinic acid (PubChem CID 10114)
- **Diseases:** Klippel–Trenaunay syndrome (MONDO:0007864)

## Full-text entities

- **Genes:** PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}
- **Diseases:** genetic disease (MESH:D030342), lymphatic malformation (MESH:D008209), venous and capillary malformations (OMIM:163000), KTS (MESH:D007715)
- **Chemicals:** oleic acid (MESH:D019301), cocum caprylate (-), quercetin (MESH:D011794), ozone (MESH:D010126), oxygen (MESH:D010100), 18-beta glycyrrhetinic acid (MESH:C119129)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12225347/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12225347/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12225347/full.md

---
Source: https://tomesphere.com/paper/PMC12225347